![]() | Only 14 pages are availabe for public view |
Abstract The virtual screening studies that have been achieved through insilico approachs indicated that the designed molecules (IVa-f, Va) would be considered as active hits as PPARγ agonists. Unfortunately, the model for the in-vitro or in-vivo screening for the PPARγ agonistic and insulin sensitizing activities were not available for us. But, since such molecular modeling studies were performed using caliberated modules and their results were statistically validated , so these in-silico studies were considered as valid tools for predicting the biological activity of the test molecules (IVa-f, Va) with high confidence. Accordingly, these active hit molecules (IVa-f, Va), were synthesized and their structures were confirmed in order to be available, in the future, for in-vivo and in-vitro evaluation as antidiabetic agents . |